1. Market Research
  2. > Business Services
  3. > Business Outsourcing Market Trends
  4. > CRO Quality Benchmarking –Phase I Service Providers (7th edition)

CRO Quality Benchmarking –Phase I Service Providers (7th edition)

  • October 2015
  • -
  • Industry Standard Research
  • -
  • 152 pages

Report Overview

In its 7th year, ISR’s “CRO Quality Benchmarking – Phase I Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality
Respondents supplied satisfaction ratings from 640 service encounters across 36 Phase I CROs, making his report the most comprehensive assessment of CRO service quality in the industry

How you can use this report:

Study Sponsors

Make a more informed purchase of Phase I services by understanding which service providers best fit your company’s needs

• Broaden your Phase I CRO evaluation list by accessing peer-based service quality ratingsacross 27 critical attributes
• Pinpoint potential delivery concerns early in a sponsor-CRO relationship/evaluation in order to develop proactive strategies to address potential gaps

Clinical Service Providers

Uncover your own — and competitor —delivery strengths and weaknesses

• Design messaging to tout your company’s strengths
• Compete more effectively by understanding buyers’ selection criteria and outsourcing trends


Over time, Industry Standard Research has accumulated a wealth of knowledge around service quality and CRO performance Understanding and utilizing this information allows stakeholders within the industry to make informed decisions when choosing a CRO for Phase I services

ISR knows that selecting a CRO isn’t easy There is a myriad of factors to evaluate for each CRO being considered Does the provider have the necessary therapeutic expertise? Will the trial be completed on time and within budget? Will the provider have sufficient access to patients? Does the lead investigator have sufficient experience? Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry

In the CRO Quality Benchmarking Phase I report, ISR provides the data necessary to answer these questions – and many more – with confidence 133 decision-makers have weighed in with their CRO selection criteria and outsourcing behaviors They have provided feedback on 640 recent service encounters across 36 Phase I CROs 19 providers have received detailed profiles, eight large CROs and 11 mid-size/specialty CROs Find out in which areas large CROs dominate and in which performance areas the smaller CROs shine

Not only does this report enable more educated purchases of CRO services, it also allows providers to get a behind-the-scenes look at customers’ perceptions of their performance Providers can determine areas of strength and understand where they may need to close the gap relative to competitors As they say, knowledge is power

Having a grasp on customer perceptions of strengths and weaknesses will help CROs effectively promote their strengths and improve areas in which they are falling short

Table Of Contents

CRO Quality Benchmarking -Phase I Service Providers (7th edition)
Copyright and Usage Guidelines 6
Introduction 7
Methodology 8
Respondent Demographics and Qualifications 9
Participant Years of Industry Experience 9
Participant Geography 9
Participant Company Size 9
Number of Ratings per Company 10
5 Major Sections 11
Sponsor Outsourcing Behaviors, Attitudes, Beliefs and Intentions 12
Primary Section 13
Figure 1 - Phase I Leadership, Familiarity, and Use 14
Figure 2 - CRO Preference 15
Figure 3 - CRO Cost Experience Among Users 16
Service Provider Selection 17
Primary Section Takeaways 18
Figure 4 - Preferred Provider Agreements 19
Figure 5 - Selecting CROs: The Influence of Preferred Provider Agreements
on Attribute Importance 20
Service Provider Performance and Loyalty 21
Primary Section Takeaways 22
Figure 6 - CRO Performance: Budget Factors 24
Figure 7 - CRO Performance: Delivery Factors 25
Figure 8 - CRO Performance: Organizational Factors 26
Figure 9 - CRO Performance: Staff Characteristic 27
Figure 10 - CRO Performance: Timelines Management 28
Customer Loyalty 29
Figure 11 - Customer Loyalty: 2015 29
Figure 12 - Customer Loyalty: 3 Year Rolling Average 30
Segment Selection Rubric and CROs to Short List 31
Figure 13 - Excellence in Project Management 32
Figure 14 - Operational Independence 33
Figure 15 - Communication Focus 34
Service Provider Profiles 35
Celerion 37
Clinical Research Services (CRS) 38
Covance 39
DCRI-Duke 40
Eurofin 41
INC Research 43
inVentiv Health Clinical 44
Medpace 45
Nuvisan 46
PPD 48
PRA 49
Premier Research 50
Quintiles 51
Quotient Clinical 52
SGS Life Sciences 53
WCCT Global 54
Worldwide Clinical Trials 55
Study Data 56
Phase I Leaders, unprompted 57
Phase I Leaders, prompted 58
Service Provider Familiarity 59
Service Provider Usage 60
Service Provider Preference 61
Service Provider Preference among Users 62
Service Provider Differentiation 63
Service Provider Cost Experience and Perception 64
Service Provider Cost Experience and Perception - Users 65
Service Provider Cost Experience and Perception - Non-users 66
Company use of Preferred Provider Agreements 67
Number of Preferred Providers 67
Selection Drivers - Preferred Providers Criterion 68
Preferred Provider Attributes Gaining Importance 69
Selection Drivers - Outside Preferred Providers 70
Selection Driver - No Preferred Providers 71
Service Provider Attributes Gaining Importance - No Preferred Providers 72
Service Provider Loyalty 73
Service Provider Loyalty - Past 3 Years 74
Service Provider Loyalty by Company Size 75
Overall Satisfaction with Service Providers 76
Willingness to Recommend Service Providers 77
Likelihood to Use Service Providers Again 78
Service Provider Drill Downs 79
Accelovance 79
Algorithme Pharma 80
Biotrial 81
Celerion 82
Chiltern 84
Clinical Research Services (CRS) 85
Covance 86
DaVita Clinical Research 87
DCRI - Duke 88
Eurofin 89
Frontage Labs 90
HungaroTrial 91
INC Research 93
inVentiv Health Clinical 94
KCR 95
Medpace 96
Nuvisan 98
Pharm-Olam International 100
PPD 101
PRA 102
Premier Research 103
Quintiles 104
Quotient Clinical 105
Rho 106
SGS Life Sciences 107
Siro Clinpharm 108
Synteract HCR 109
Theorem 110
TKL Research 111
US Oncology 112
WCCT Global 113
Worldwide Clinical Trials 114
CRO Satisfaction Rating Explanations 115
Performance across Service Providers 129
Access to “unique” tests, machines, equipment 129
Access to a broad range of services beyond clinic / volunteer management 130
Access to patient populations 130
Clinic availability 131
Data quality 131
Easy to work with 132
Experience of the Phase I unit's lead investigator 132
Financial strength / stability 133
Local market/Regulatory knowledge 133
Location of Phase I unit(s) in different global regions 134
Location of Phase I unit(s) within your country 134
Low cost 135
Meeting overall project timelines 135
Minimizing change orders 136
Minimizing staff turnover 136
Offered innovative solutions 137
Operational excellence 137
Patient/Volunteer recruitment 138
Project manager quality 138
Project team chemistry 139
Responsiveness 139
Scientific knowledge 140
Speed of site start-up 140
Technology for real-time access to data 141
Therapeutic expertise 141
Timely project communications 142
Up-front contingency planning, risk management 142
Demographics 143
Phase Experience 144
Type of Company 145
Decision Making Responsibility 146
Office Location 147
Job Level 147
Clinical Development Involvement 148
Therapeutic Areas of Responsibility 149
Years in Pharmaceutical and Biotechnology Industry 150
Age 151
About Industry Standard Research 152

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

  • $ 19000
  • Industry report
  • January 2017
  • by WinterGreen Research

This 2017 module has 138 pages and 67 tables and figures Worldwide hyperscale data center markets implement cloud computing with shared resource and the aim, more or less achieved of providing foolproof ...

Asia-Pacific Network-based Advanced Malware Analysis (NAMA) Solutions Market

Asia-Pacific Network-based Advanced Malware Analysis (NAMA) Solutions Market

  • $ 15000
  • Industry report
  • December 2016
  • by Frost & Sullivan

The Need to Defend Against Zero-day and Ransomware Attacks Driving the Adoption of NAMA Solutions The network-based advanced malware analysis solutions market in Asia-Pacific (APAC) continued to maintain ...

Network orchestration and management systems: worldwide forecast 2016–2020

Network orchestration and management systems: worldwide forecast 2016–2020

  • $ 7999
  • Industry report
  • December 2016
  • by Analysys Mason

"Communications service providers should not go too far down the network virtualisation path without implementing a network orchestration strategy." Spending on traditional network management systems (NMS) ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.